The African-centric P47S Variant of TP53 Confers Immune Dysregulation and Impaired Response to Immune Checkpoint Inhibition.
David C StiegJoshua L D ParrisTyler Hong Loong YangGauri MirjiSarah Kim ReiserNivitha MuraliMadison WertsThibaut BarnoudDavid Y LuRahul S ShindeMaureen E MurphyDaniel T ClaibornePublished in: Cancer research communications (2023)
has been shown to negatively impact the immune microenvironment and the response to immunotherapy.
Keyphrases